longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Akso Health

AHG

0.839214.93% ( +0.1090 )
Closed: Sep 11, 16:00:00 (EDT)
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -24.80, within the reasonable range, cheaper than 70.63% of the time in the past 3 years, and the industry ranks 13/14, the industry Median -0.18.

-24.8xP/E
$0.84Stock price
$-0.03Earnings per share
-24.8xP/E
Stock price$0.84Earnings per share$-0.03

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-9.64x
Typical range
-38.83x–-5.71x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
08162432

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x10x20x30x40x50x
P/E ratio
Name/Symbol
AHCOUSAdaptHealth
-3.63x145.14%$826.25M
AHGUSAkso Health
-24.80x--$463.12M
ACHUSAccendra Health
-0.27x89.03%$83.06M
COSMUSCosmos Health
-1.05x66.67%$25.52M
ZSTKUSZeroStack
-0.07x90.76%$11.77M
POMUSPomdoctor
-0.18x--$5.44M
MEDSUSDataMeds AI
-0.03x--$2.76M
ATPCUSAgape ATP
-2.10x--$2.38M
VRAXUSVirax Biolabs
-0.42x52.53%$2.13M
BIMIUSBIMI International Medical
----$6.98K

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.